SAINT BELLA GP disclosed that it repurchased 281,000 ordinary shares on 20 July 2026 through on-exchange transactions, paying between HKD 3.11 and HKD 3.24 per share. The volume-weighted average repurchase price was HKD 3.17, bringing total consideration to HKD 0.89 million.
Following the transaction, issued shares outstanding (excluding treasury shares) fell 0.05% to 620.77 million, while treasury shares increased to 1.43 million. Total issued share capital remained unchanged at 622.20 million shares.
The buyback formed part of the mandate approved on 30 June 2026, which authorises the repurchase of up to 62.22 million shares. Cumulative repurchases under this mandate now stand at 1.43 million shares, equivalent to 0.23% of the company’s issued shares on the mandate date.
In accordance with Hong Kong Listing Rules, the company is restricted from issuing new shares or disposing of treasury shares until 19 August 2026.
Comments